Where does David H. Crean work?

David H. Crean is General Partner at 1004 Venture Partners.

What check size does David H. Crean write?

David H. Crean typically writes checks of $250K – $10M.

David H. Crean

Investor

General Partner at 1004 Venture Partners

San Diego, California

Writes $250K – $10M checks · typically $500K

About

David H. Crean is Managing Partner of Cardiff Advisory LLC, an advisory firm serving life sciences and healthcare companies on mergers and acquisitions, licensing, valuations, and corporate strategy. He serves as Chief Business Officer of MediciNova (NASDAQ: MNOV), leading corporate development, partnering, investor relations, and capital markets strategy, and holds board positions including Chairman of Paracrine Inc. and Lead Independent Director of Cenna Biosciences. Over 30 years in life sciences and capital markets, Crean has advised more than 250 companies and completed more than 50 transactions exceeding $1 billion in aggregate value, with prior roles including Senior Director of Corporate Development at Allergan and Managing Director of Healthcare & Life Sciences at Objective Capital Partners.

Experience

Cardiff Advisory LLCManaging Partnercurrent2021 — presentSan Diego, California
MediciNova, Inc.Chief Business Officer, Head of Investor & Public Relations and Communicationscurrent2021 — presentSan Diego, CA
CEOthreesixty (CEO360,LLC)Co-Founder, Healthcare and Life Sciencescurrent2023 — presentSan Diego, San Francisco, California
BioClarus ConsultingPartnercurrent2026 — presentSan Diego, CA
Snell & WilmerForum Leader - Artificial Intelligence (AI) Leadership Collectivecurrent2025 — presentPalo Alto, CA
REFForum Leader - Life Sciences and Healthcarecurrent2024 — presentSan Diego, California, United States
ConnectMember Board of Directorscurrent2024 — presentSan Diego, California, United States
Paracrine, Inc.Chairman of the Board of Directorscurrent2023 — presentSan Diego, California, United States
Paracrine, Inc.Member Board of Directors2022 — 2023San Diego, California, United States
Biocom CaliforniaBoard of Governor's | Chairman, Capital Development (Partnering & Fundraising)current2022 — presentCalifornia, United States
Cenna BiosciencesMember Board of Directorscurrent2023 — presentSan Diego, California, United States
1004 Venture PartnersVenture Partner2024 — 2026San Francisco, California
VU Venture PartnersVenture Partner2024 — 2025San Francisco, California, United States
California Life Sciences (CLS)Member Board of Directors2018 — 2024San Francisco Bay Area
Procopio, Cory, Hargreaves & Savitch LLPChair, CEO Roundtable Connection - Life Sciences2023 — 2024Palo Alto, California, United States
ImmunogenXChief Business Officer2023 — 2024Newport Beach, California, United States
HistogenLead Independent Director, Audit and Scientific Committees2021 — 2024San Diego, California, United States
HistogenChairman Of The Board Of Directors2020 — 2021San Diego, California, United States
HistogenAudit Committee Chair; Governance and Compensation Committees2018 — 2021Greater San Diego Area
Venture InstituteVenture Member, Cohort 22023Palo Alto, California, United States

Education

University at Buffalo Pharmacy and Pharmaceutical SciencesDoctor of Philosophy (Ph.D.), Biophysics
Pepperdine UniversityMaster of Business Administration, Finance
University at BuffaloMaster of Science (M.S.), Natural Sciences / Oncology
Canisius UniversityBachelor of Science (B.S.), PreMed & Sports Medicine
The Ohio State UniversityEngineering1982 — 1984
University at BuffaloDoctor of Philosophy, Biophysics

Skills & more

Corporate DevelopmentBoard Governance7Strategic PartnershipsMergers & Acquisitions (M&A)2Business Valuation18Venture Financing4Capital FormationEntrepreneurship28Medical Diagnostics2EquitiesMedical Technology41Capital Markets38

+12 more

Venture ManagementPublic RelationsCorporate Venture CapitalInvestmentsValuationPortfolio ManagementStart-up VenturesPrivate EquityNegotiationMentoringEquity FinancingDebt Financing

Series 79 - Investment Banking Representative — FINRA
Series 63 - Uniform State Law Securities License — FINRA

From David's professional profile.

Deals · 1

HistogenBoard seat

via 1004 Venture Partners · filed Jul 2022 · $5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at 1004 Venture Partners

Soyoung Park

General Partner at 1004 Venture Partners

Network1

André ZimmermannScout

Partner at SHS Capital

Investors connected to David in public investor directories — a warm-intro map.

Frequently asked questions

Where does David H. Crean work?: David H. Crean is General Partner at 1004 Venture Partners.
What check size does David H. Crean write?: David H. Crean typically writes checks of $250K – $10M.

Same school

Also attended University at Buffalo Pharmacy and Pharmaceutical Sciences1

Doug WilliamsBiotech Executive & Founding Pillar at Pillar VC

Also attended Pepperdine University30

Kenneth KellerAssociate at Marlin Equity Partners Dr. John L Evans JrVenture Partner at Parkway Venture Capital Kelly KoVice President of Technology Ventures and Innovation at Flare Capital Partners Jerel DavisManaging Director at Versant Ventures Jasmine EssalatSenior Recruiter at Red Cell Incubation Nia PatelVice President at Electric Feel Ventures Llc

+ 24 more

Also attended Canisius University10

Amber ManteHead of Human Intelligence at Theory Ventures Marguerite BensonSenior Advisor at Audere Capital Matt EnsticeAdvisor at Commonweal Ventures Thomas BergerBestuurder at Angelwise Will SchererAssociate at Sopris Private Equity Vladimir LukicManaging Director & Senior Partner; Global Leader, Tech and Digital Advantage Practice at The Boston Consulting Group

+ 4 more

Also attended The Ohio State University109

Keatten SmithCapital Formation Coordinator at March Capital Partners Sara Risch, PhDAdvisor at CincyTech Will McKelveyPrincipal at Lerer Hippeau Laura SebastianiVP of Finance at Scale Venture Partners Suresh BalasubramanianInvestor at Storm Ventures John D. SimonExecutive Venture Partner at Caduceus Capital Partners

+ 103 more

Shared employers